• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nexalin Technology, Inc. - Common Stock (NQ:NXL)

    0.4412 +0.0114 (+2.65%)
    Streaming Delayed Price Updated: 12:25 PM EDT, Apr 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 713,195
    Open 0.4211
    Bid (Size) 0.4390 (100)
    Ask (Size) 0.4500 (300)
    Prev. Close 0.4298
    Today's Range 0.4100 - 0.5090
    52wk Range 0.3302 - 2.310
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
    Company Designing FDA Application Amendments and U.S. Clinical Strategy Leveraging Extensive Real-World Neurostimulation Data Sets Reflecting Broad Clinical Experiences 
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
    From Nexalin Technology, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -24.3%
    -24.3%
    1 Month
    +8.5%
    +8.5%
    3 Month
    -35.1%
    -35.1%
    6 Month
    -65.8%
    -65.8%
    1 Year
    -75.2%
    -75.2%

    More News

    Read More
    News headline image
    Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
    Via ACCESS Newswire
    News headline image
    Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology and First Phosphate Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    Unusual volume stocks in Friday's session ↗
    Via Chartmill
    News headline image
    Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Discover the top movers in Thursday's pre-market session. ↗
    Via Chartmill
    Top movers in Tuesday's pre-market session ↗
    Via Chartmill
    News headline image
    Nexalin Highlights its Expanding Body of Peer-Reviewed Neuroimaging Research Confirming its DIFS™ Technology as the Leader in Evidenced-Based Non-Invasive Brain Stimulation
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Receives Nasdaq Listing Status Notification
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESS Newswire
    News headline image
    Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer’s and Traumatic Brain Injury Programs
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit
    From Nexalin Technology, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Nexalin Technology, Inc. - Common Stock publicly traded?
    Yes, Nexalin Technology, Inc. - Common Stock is publicly traded.
    What exchange does Nexalin Technology, Inc. - Common Stock trade on?
    Nexalin Technology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Nexalin Technology, Inc. - Common Stock?
    The ticker symbol for Nexalin Technology, Inc. - Common Stock is NXL on the Nasdaq Stock Market
    What is the current price of Nexalin Technology, Inc. - Common Stock?
    The current price of Nexalin Technology, Inc. - Common Stock is 0.4412
    When was Nexalin Technology, Inc. - Common Stock last traded?
    The last trade of Nexalin Technology, Inc. - Common Stock was at 04/15/26 12:25 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.